Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Coudrat

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 10, 2025
Structure activity relationship exploration of imidazo[1,2-a]pyridine series to reverse isoform selectivity and identify potent SIK1 selective inhibitorsChristophe Peixoto, Elsa De Lemos, Laëtitia Cherel, et al.
Nature|April 25, 2017
Phase-plate cryo-EM structure of a class B GPCR-G-protein complexYi-Lynn Liang, Maryam Khoshouei, Mazdak Radjainia, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 10, 2025
Structure activity relationship exploration of imidazo[1,2-a]pyridine series to reverse isoform selectivity and identify potent SIK1 selective inhibitorsChristophe Peixoto, Elsa De Lemos, Laëtitia Cherel, et al.
Nature|April 25, 2017
Phase-plate cryo-EM structure of a class B GPCR-G-protein complexYi-Lynn Liang, Maryam Khoshouei, Mazdak Radjainia, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 2